מדינה: ארצות הברית
שפה: אנגלית
מקור: NLM (National Library of Medicine)
Isotretinoin (UNII: EH28UP18IF) (Isotretinoin - UNII:EH28UP18IF)
Mayne Pharma
ORAL
PRESCRIPTION DRUG
Isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, isotretinoin capsules are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. Limitations of Use : If a second course of isotretinoin therapy is needed, it is not recommended before a two-month waiting period because the patient's acne may continue to improve following a 15 to 20-week course of therapy [see Dosage and Administration (2.2)] . Isotretinoin capsules are contraindicated in pregnancy [see Warnings and Precautions (5.1) and Use in Specific Populations (8.1)] . Isotretinoin capsules are contraindicated in patients with hypersensitivity to isotretinoin (or Vitamin A, given the chemical similarity to isotretinoin) or to any of its components (anaphylaxis an
Isotretinoin Capsules, USP 40 mg is supplied as pink-brown, oblong, soft gelatin capsule, containing a yellow/orange opaque viscous liquid, imprinted "575" in black ink. They are supplied as follows: Box of 30 capsules (3 × 10 Prescription Packs): NDC 68308-575-30 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursion permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Protect from light.
Abbreviated New Drug Application
Mayne Pharma ---------- MEDICATION GUIDE ISOTRETINOIN (EYE'' SOE TRET' I NOYN) CAPSULES, USP This Medication Guide has been approved by the U.S. Food and Drug Administration. Issued: 9/2022 Read the Medication Guide that comes with isotretinoin capsules before you start taking it and each time you get a prescription. There may be new information. This information does not take the place of talking with your healthcare provider about your medical condition or your treatment. What is the most important information I should know about isotretinoin capsules? • Isotretinoin capsules can harm your unborn baby, including birth defects (deformed babies), loss of a baby before birth (miscarriage), death of the baby, and early (premature) births. Patients who are pregnant or who plan to become pregnant must not take isotretinoin capsules. Patients must not get pregnant: • for 1 month before starting isotretinoin capsules • during treatment with isotretinoin capsules • for 1 month after stopping isotretinoin capsules If you get pregnant during treatment with isotretinoin capsules, stop taking it right away and call your healthcare provider. Healthcare providers and patients should report all cases of pregnancy during treatment or 1 month after stopping treatment to: • FDA MedWatch at 1-800-FDA-1088, and • the iPLEDGE Pregnancy Registry at 1-866-495-0654 or www.ipledgeprogram.com Because isotretinoin capsules can cause birth defects, isotretinoin capsules are only for patients who can understand and agree to carry out all of the instructions in the iPLEDGE REMS. • Serious mental health problems, including: • depression • psychosis (seeing or hearing things that are not real) • suicide. Some patients taking isotretinoin capsules have had thoughts about hurting themselves or putting an end to their own lives (suicidal thoughts). Some people tried to end their own lives. Some people have ended their own lives. Stop taking isotretinoin capsules and call your healthcare provider right away if you or a family m קרא את המסמך השלם
ISOTRETINOIN- ISOTRETINOIN CAPSULE, LIQUID FILLED MAYNE PHARMA ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE ISOTRETINOIN CAPSULES SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ISOTRETINOIN CAPSULES. ISOTRETINOIN CAPSULES, FOR ORAL USE INITIAL U.S. APPROVAL: 1982 WARNING: EMBRYO-FETAL TOXICITY – CONTRAINDICATED IN PREGNANCY _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ ISOTRETINOIN CAPSULES CAN CAUSE LIFE-THREATENING BIRTH DEFECTS AND IS CONTRAINDICATED IN PREGNANCY. THERE IS AN EXTREMELY HIGH RISK THAT LIFE-THREATENING BIRTH DEFECTS WILL RESULT IF PREGNANCY OCCURS WHILE TAKING ISOTRETINOIN CAPSULES IN ANY AMOUNT, EVEN FOR SHORT PERIODS OF TIME. POTENTIALLY ANY FETUS EXPOSED DURING PREGNANCY CAN BE AFFECTED. THERE ARE NO ACCURATE MEANS OF DETERMINING WHETHER AN EXPOSED FETUS HAS BEEN AFFECTED. (4, 5.1, 8.1) ISOTRETINOIN CAPSULES ARE AVAILABLE ONLY THROUGH A RESTRICTED PROGRAM CALLED THE IPLEDGE REMS. (5.2) INDICATIONS AND USAGE Isotretinoin capsules are retinoids indicated for the treatment of severe recalcitrant nodular acne in non- pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, isotretinoin capsules are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. (1) Limitations of Use: If a second course of isotretinoin therapy is needed, it is not recommended before a two-month waiting period because the patient's acne may continue to improve following a 15 to 20-week course of therapy. (1) DOSAGE AND ADMINISTRATION Recommended dosage for ISOTRETINOIN CAPSULES IS 0.5 TO 1 MG/KG/DAY given in two divided doses without regard to meals for 15 to 20 weeks (2.1) Adult patients with very severe disease (scarring, trunk involvement) may increase dosage to 2 mg/kg/day of isotretinoin capsules in divided doses. (2.1) Once d קרא את המסמך השלם